These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 22388515)

  • 21. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H; Ngo VC; Fargnoli J; Ayers M; Soo KC; Koong HN; Thng CH; Ong HS; Chung A; Chow P; Pollock P; Byron S; Tran E
    Clin Cancer Res; 2008 Oct; 14(19):6146-53. PubMed ID: 18829493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibroblast growth factor signaling in Caenorhabditis elegans.
    Borland CZ; Schutzman JL; Stern MJ
    Bioessays; 2001 Dec; 23(12):1120-30. PubMed ID: 11746231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemotactic migration of mesencephalic neural crest cells in the mouse.
    Kubota Y; Ito K
    Dev Dyn; 2000 Feb; 217(2):170-9. PubMed ID: 10706141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
    Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
    Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent developments and advances of FGFR as a potential target in cancer.
    Xue WJ; Li MT; Chen L; Sun LP; Li YY
    Future Med Chem; 2018 Sep; 10(17):2109-2126. PubMed ID: 30066580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AZD4547: an orally bioavailable, potent, and selective inhibitor of the fibroblast growth factor receptor tyrosine kinase family.
    Gavine PR; Mooney L; Kilgour E; Thomas AP; Al-Kadhimi K; Beck S; Rooney C; Coleman T; Baker D; Mellor MJ; Brooks AN; Klinowska T
    Cancer Res; 2012 Apr; 72(8):2045-56. PubMed ID: 22369928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents.
    Herbert C; Lassalle G; Alcouffe C; Bono F
    Pharm Pat Anal; 2014; 3(6):585-612. PubMed ID: 25489913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting fibroblast growth factor receptor signaling in hepatocellular carcinoma.
    Cheng AL; Shen YC; Zhu AX
    Oncology; 2011; 81(5-6):372-80. PubMed ID: 22269894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FGF-FGFR signaling in vertebrate organogenesis.
    Kato S; Sekine K
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):631-8. PubMed ID: 10512194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct FGF receptor 1 activation through an anti-idiotypic strategy mimicks the biological activity of FGF-2 and inhibits the progression of the bladder carcinoma derived from NBT-II cells.
    Malavaud B; Pedron S; Sordello S; Mazerolles C; Billottet C; Thiery JP; Jouanneau J; Plouët J
    Oncogene; 2004 Sep; 23(40):6769-78. PubMed ID: 15273729
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
    Dianat-Moghadam H; Teimoori-Toolabi L
    Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small-molecule inhibitors of fibroblast growth factor receptor (FGFR) tyrosine kinases (TK).
    Manetti F; Botta M
    Curr Pharm Des; 2003; 9(7):567-81. PubMed ID: 12570804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers.
    Chaffer CL; Dopheide B; Savagner P; Thompson EW; Williams ED
    Differentiation; 2007 Nov; 75(9):831-42. PubMed ID: 17697126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blocking the FGF/FGFR system as a "two-compartment" antiangiogenic/antitumor approach in cancer therapy.
    Giacomini A; Chiodelli P; Matarazzo S; Rusnati M; Presta M; Ronca R
    Pharmacol Res; 2016 May; 107():172-185. PubMed ID: 27013279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibroblast growth factor receptors as therapeutic targets in clear-cell renal cell carcinoma.
    Sonpavde G; Willey CD; Sudarshan S
    Expert Opin Investig Drugs; 2014 Mar; 23(3):305-15. PubMed ID: 24387233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of tumor angiogenesis and growth by a small-molecule multi-FGF receptor blocker with allosteric properties.
    Bono F; De Smet F; Herbert C; De Bock K; Georgiadou M; Fons P; Tjwa M; Alcouffe C; Ny A; Bianciotto M; Jonckx B; Murakami M; Lanahan AA; Michielsen C; Sibrac D; Dol-Gleizes F; Mazzone M; Zacchigna S; Herault JP; Fischer C; Rigon P; Ruiz de Almodovar C; Claes F; Blanc I; Poesen K; Zhang J; Segura I; Gueguen G; Bordes MF; Lambrechts D; Broussy R; van de Wouwer M; Michaux C; Shimada T; Jean I; Blacher S; Noel A; Motte P; Rom E; Rakic JM; Katsuma S; Schaeffer P; Yayon A; Van Schepdael A; Schwalbe H; Gervasio FL; Carmeliet G; Rozensky J; Dewerchin M; Simons M; Christopoulos A; Herbert JM; Carmeliet P
    Cancer Cell; 2013 Apr; 23(4):477-88. PubMed ID: 23597562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice.
    Raj T; Kanellakis P; Pomilio G; Jennings G; Bobik A; Agrotis A
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1845-51. PubMed ID: 16709940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of fibroblast growth factors in tumor growth.
    Korc M; Friesel RE
    Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.